Australien - engelska - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - timolol maleate, quantity: 6.8 mg/ml (equivalent: timolol, qty 5 mg/ml); bimatoprost, quantity: 0.3 mg/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate heptahydrate; benzalkonium chloride; sodium hydroxide; purified water; citric acid monohydrate; hydrochloric acid; sodium chloride - ganfort eye drops are indicated for the reduction of intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension who are insufficiently responsive to monotherapy.

Israel - engelska - Ministry of Health

novartis israel ltd - timolol as maleate; travoprost - ophthalmic solution - travoprost 40 mcg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intraocular pressure (iop) in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Storbritannien - engelska - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - timolol maleate - eye drops - 2.5mg/1ml

USA - engelska - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see warnings); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see warnings); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.

USA - engelska - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol maleate ophthalmic solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. timolol maleate ophthalmic solution is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see warnings); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see warnings); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.

Kanada - engelska - Health Canada

jamp pharma corporation - dorzolamide (dorzolamide hydrochloride); timolol (timolol maleate) - solution - 20mg; 5mg - dorzolamide (dorzolamide hydrochloride) 20mg; timolol (timolol maleate) 5mg - beta-adrenergic agents

Israel - engelska - Ministry of Health

rafa laboratories ltd - timolol as maleate - eye drops, solution - timolol as maleate 5 mg/ml - timolol - timolol - for the reduction of elevated intraocular pressure may be used in patients with chronic open-angle glaucoma, aphakic glaucoma, some patients with secondary glaucoma and patients with ocular hypertension

Israel - engelska - Ministry of Health

taro international ltd, israel - dorzolamide as hydrochloride; timolol as maleate - eye drops, solution - timolol as maleate 5 mg/ml; dorzolamide as hydrochloride 20 mg/ml - dorzolamide - for the treatment of elevated intraocular pressure (iop ) in patients with ocular hypertension, open-angle glaucoma, or other secondary open-angle glaucoma when concomitant therapy is appropriate

Malta - engelska - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - timolol - eye drops, solution - timolol 2.5 mg/ml - ophthalmologicals

Malta - engelska - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - timolol - eye drops, solution - timolol 5 mg/ml - ophthalmologicals